TrialCancer immunology, immunotherapy : CII2018

Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.

Yu Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.